IMAC Holdings and Brain Scientific Announce a Strategic Merger to Create Synergistic End-To-End Neurological Solution
Brain Scientific Sees Increased First-Quarter Sales Momentum and Revenue Growth
Life After PTSD and Brain Scientific Form Collaboration to Tackle PTSD
MVAP Medical Supplies Submits Major Order for NeuroCaps, Sees Huge Opportunity in Pediatrics
Brain Scientific Partners With SysteMedic, Receives First Purchase Order for NeuroCaps in Israel
Neurology Medtech Brain Scientific Files for Nasdaq Uplisting, $13M Offering
Brain Scientific Signs Agreement With MVAP Medical Supplies to Go After Rapidly Growing Pediatric Neurodiagnostic Space
Brain Scientific Inks Deal With Fulcrum to Go After At-Home Diagnostic Space, Hires VP of Marketing and Communications
Brain Scientific Announces Release of Improved NeuroCap(TM) and New US Distribution Deal With D&D Medical
Press Release: Daniel Cloutier, a Veteran Sales Executive, Joins Brain Scientific as Chief Revenue Officer
Brain Scientific Announces CE Mark Approval for NeuroCap™ Device
Brain Scientific to raise $5.6M in senior debentures, converted $12.9 in existing debt into equity
Brain Scientific Announces Private Placement of $5.6 Million of Senior Secured Convertible Debentures and Warrants, Converts Approximately $12.9 Million of Existing Debt into Equity
Piezo Motion Expands Reach into South America
Piezo Motion Launches High-Precision, Standing Wave-Type Line of Motors Ahead of the Energy, Drone & Robotics Summit
Brain Scientific reports Q1 results
Brain Scientific Announces First Quarter 2022 Results
Top upgrades and downgrades on 5/5
NATO Center of Excellence for Military Medicine to Study Brain Scientific’s NeuroCap Device
Piezo Motion Expands Reach to Eastern Europe
No Data
No Data